HIGHLIGHTS
- who: H. S. Gabry&sacute from the University of Sassari, Italy have published the paper: PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors, in the Journal: (JOURNAL)
- what: Purpose Purpose: This study evaluated pretreatment 2[18F]fluoro-2-deoxy-D-glucose (FDG)-PET/CT-based radiomic signatures for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibition (ICI). In this exploratory study, the authors aimed to evaluate the value of radiomic signatures for early prediction of PD-HPD from pre-treatment CT and FDG . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.